We have focused on the Drug Delivery System*, and proceeded with development of film type of pharmaceuticals (Oral Thin Films and Transdermal Patches). By utilizing our Core Technologies, we believe that we can contribute to improvements in dosage compliance and quality of life (QOL) for patients and aim for contribution to realize the enrichment of people’s lives. We performs contract development of Oral Thin Films, and Nissha Zonnebodo Pharma, a Nissha company, plans to provide contract manufacturing of them.

For pharmaceuticals and quasi-drugs (own brand), Nissha Group develops and manufactures, please click here.

*A dosing system designed for efficiently delivering the required amount of drug into the targeted site in the body for the required time.

The thin film dissolves quickly in the mouth and is absorbed into the body. Since it be orally taken without water, and is suitable for elderly patients with swallowing difficulties and bedridden patients.

Nissha innovated the original manufacturing process (patented) of oral thin films, which realizes reducing the pressure loading on drug substances and the loss of raw materials. Our process is expected to expand possibilities in existing drug formulation development.

• The process that suppresses the amount of solvent, the amount of heat transferred to drug substances and pressure loading as much as possible.
• Customizable in thickness and shape
• Minimize raw material loss between processes

The patch type formulation is applied to the skin, allowing the drug to directly enter the bloodstream. Compared to oral administration, this method reduces gastrointestinal side effects, improves drug absorption, and maintains stable blood concentration.